Tysabri® Celebrates One-Year Anniversary As A Treatment For Multiple Sclerosis
Medical News Today Mon, 06 Aug 2007 1:13 AM PDT
Biogen Idec (NASDAQ: BIIB) and Elan Corporation, plc (NYSE: ELN) announced the one-year anniversary of TYSABRI® (natalizumab) as a treatment for relapsing forms of multiple sclerosis (MS). [click link for full article]
Medical News Today Mon, 06 Aug 2007 1:13 AM PDT
Biogen Idec (NASDAQ: BIIB) and Elan Corporation, plc (NYSE: ELN) announced the one-year anniversary of TYSABRI® (natalizumab) as a treatment for relapsing forms of multiple sclerosis (MS). [click link for full article]
posted by Bill at 11:31 AM
0 Comments:
Post a Comment
<< Home